Daesung Microbiological Labs. Co. Ltd (036480) — Cash Flow Quality Index
Daesung Microbiological Labs. Co. Ltd (036480) has a Cash Flow Quality Index of 4.00x as of December 2025. Operating cash flow of ₩972.26 Million exceeds net income of ₩243.19 Million, indicating high earnings quality where cash backs reported profits. Explore 036480 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Daesung Microbiological Labs. Co. Ltd Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Daesung Microbiological Labs. Co. Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Daesung Microbiological Labs. Co. Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Daesung Microbiological Labs. Co. Ltd (2012–2025)
Year-by-year earnings quality comparison for Daesung Microbiological Labs. Co. Ltd. For live market cap and the full company financial profile, see Daesung Microbiological Labs. Co. Ltd (036480) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.36x | ₩1.41 Billion | ₩598.19 Million | ▲ +247.5% |
| 2022 | 0.68x | ₩1.16 Billion | ₩1.70 Billion | ▼ -73.3% |
| 2021 | 2.54x | ₩2.20 Billion | ₩865.92 Million | ▲ +19.4% |
| 2020 | 2.13x | ₩3.24 Billion | ₩1.52 Billion | ▲ +162.3% |
| 2019 | 0.81x | ₩2.32 Billion | ₩2.85 Billion | ▼ -17.9% |
| 2018 | 0.99x | ₩3.14 Billion | ₩3.17 Billion | ▼ -8.3% |
| 2017 | 1.08x | ₩1.68 Billion | ₩1.56 Billion | ▲ +37.7% |
| 2016 | 0.78x | ₩3.52 Billion | ₩4.49 Billion | ▼ -53.5% |
| 2015 | 1.68x | ₩7.66 Billion | ₩4.55 Billion | ▼ -10.3% |
| 2014 | 1.88x | ₩3.83 Billion | ₩2.04 Billion | ▼ -57.0% |
| 2013 | 4.36x | ₩1.89 Billion | ₩433.00 Million | ▼ -16.6% |
| 2012 | 5.23x | ₩2.33 Billion | ₩446.00 Million | — |